Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seok-Jin Kim

Showing results (31-40 of 474) with videos related to

Pageof 48
Sort By:
Scientific Reports|July 17, 2023
Clinical relevance of deep learning models in predicting the onset timing of cancer pain exacerbationYeong Hak Bang, Yoon Ho Choi, Mincheol Park, et al.
Cancer Research and Treatment|August 20, 2024
Nivolumab in Relapsed or Refractory Primary Central Nervous System Lymphoma: Multicenter, Retrospective StudyJun Ho Yi, Seok Jin Kim, Sang-A Kim, et al.
Journal of Hematology & Oncology|May 14, 2015
The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patientsSeok Jin Kim, Kyung Ju Ryu, Mineui Hong, et al.
Journal of Neuro-Oncology|December 2, 2021
Selective salvage radiotherapy could provide favorable outcomes in patients with refractory or relapsed primary central nervous system lymphomaNalee Kim, Do Hoon Lim, Sang Eun Yoon, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeDongryul Oh, Yong Chan Ahn, Seok Jin Kim, et al.
Blood Research|October 23, 2025
Aggressive natural killer cell leukemia therapy in the L-asparaginase era: why are we failing?Sang Eun Yoon, Junhun Cho, Hyun-Young Kim, et al.
Journal of Neuro-Oncology|July 31, 2021
Role of 23.4 Gy upfront whole-brain radiation therapy following high-dose methotrexate for primary central nervous system lymphoma: a comparative analysis of whole-brain radiation therapy versus no radiation therapyNalee Kim, Do Hoon Lim, Sang Eun Yoon, et al.
Annals of Hematology|August 5, 2024
Delphi consensus recommendations on treatment for advanced-stage marginal zone lymphoma in South KoreaSeok Jin Kim, Seug Yun Yoon, Sharon Chua, et al.
Scientific Reports|July 25, 2022
Lymphoma total lesion glycolysis leads to hyperlactatemia and reduction of brain glucose utilizationHyun Kyung Yi, Jang Yoo, Seok Jin Kim, et al.
Nature Reviews. Chemistry|April 28, 2025
Structural control over single-crystalline oxides for heterogeneous catalysisSeok-Jin Kim, Raghu V Maligal-Ganesh, Javeed Mahmood, et al.
Pageof 48

Showing results (31-40 of 474) with videos related to

Sort By:
Pageof 48
Scientific Reports|July 17, 2023
Clinical relevance of deep learning models in predicting the onset timing of cancer pain exacerbationYeong Hak Bang, Yoon Ho Choi, Mincheol Park, et al.
Cancer Research and Treatment|August 20, 2024
Nivolumab in Relapsed or Refractory Primary Central Nervous System Lymphoma: Multicenter, Retrospective StudyJun Ho Yi, Seok Jin Kim, Sang-A Kim, et al.
Journal of Hematology & Oncology|May 14, 2015
The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patientsSeok Jin Kim, Kyung Ju Ryu, Mineui Hong, et al.
Journal of Neuro-Oncology|December 2, 2021
Selective salvage radiotherapy could provide favorable outcomes in patients with refractory or relapsed primary central nervous system lymphomaNalee Kim, Do Hoon Lim, Sang Eun Yoon, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeDongryul Oh, Yong Chan Ahn, Seok Jin Kim, et al.
Blood Research|October 23, 2025
Aggressive natural killer cell leukemia therapy in the L-asparaginase era: why are we failing?Sang Eun Yoon, Junhun Cho, Hyun-Young Kim, et al.
Journal of Neuro-Oncology|July 31, 2021
Role of 23.4 Gy upfront whole-brain radiation therapy following high-dose methotrexate for primary central nervous system lymphoma: a comparative analysis of whole-brain radiation therapy versus no radiation therapyNalee Kim, Do Hoon Lim, Sang Eun Yoon, et al.
Annals of Hematology|August 5, 2024
Delphi consensus recommendations on treatment for advanced-stage marginal zone lymphoma in South KoreaSeok Jin Kim, Seug Yun Yoon, Sharon Chua, et al.
Scientific Reports|July 25, 2022
Lymphoma total lesion glycolysis leads to hyperlactatemia and reduction of brain glucose utilizationHyun Kyung Yi, Jang Yoo, Seok Jin Kim, et al.
Nature Reviews. Chemistry|April 28, 2025
Structural control over single-crystalline oxides for heterogeneous catalysisSeok-Jin Kim, Raghu V Maligal-Ganesh, Javeed Mahmood, et al.
Pageof 48